Enovis

Enovis

Yahoo Finance • 22 days ago

Enovis reaffirms 2026 outlook and targets >25% free cash flow conversion as Arvis rollout expands

Earnings Call Insights: Enovis (ENOV) Q2 2026 MANAGEMENT VIEW * CEO Damien McDonald said Q2 results showed “the strength and stability of our diversified product portfolio” and reported “organic growth of 5%, driven by 6% organic growt... Full story

Yahoo Finance • 23 days ago

Enovis Announces Second Quarter 2026 Results

Second-quarter sales growth of 3% on a reported basis, 5% organicSecond-quarter Reconstructive sales grew 8% on a reported basis, 6% organicReaffirmed full-year 2026 guidance for revenue, adjusted EBITDA, adjusted EPS, and Free Cash Flow C... Full story

Yahoo Finance • last month

STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know

STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans... Full story

Yahoo Finance • last month

Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis

Check out the companies making headlines this week: HCA Healthcare (NYSE:HCA): Hospital operator HCA Healthcare (NYSE:HCA) fell by 6.7% on Tuesday after the company released preliminary second-quarter results and cut its full-year 2026 pr... Full story

Yahoo Finance • last month

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Dallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quart... Full story

Yahoo Finance • 2 months ago

Why Enovis (ENOV) Stock Is Trading Up Today

Why Enovis (ENOV) Stock Is Trading Up Today What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 15% in the afternoon session after the Centers for Medicare & Medicaid Services reversed previously ann... Full story

Yahoo Finance • 2 months ago

4 Top Growth Stocks Worth Buying Under $100 Today

Key Points Enovis is capitalizing on rising demand for joint replacements, with double-digit reconstructive growth, and Wall Street sees significant upside potential. Insteel Industries benefits from infrastructure spending and booming da... Full story

Yahoo Finance • 2 months ago

1 Oversold Stock Primed to Rebound and 2 We Find Risky

1 Oversold Stock Primed to Rebound and 2 We Find Risky The past year hasn't been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether they're witnessing fire s... Full story

Yahoo Finance • 2 months ago

These small-cap healthcare stocks pair revenue growth with attractive valuations

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Healthcare stocks have remained in focus as investors look for companies that can deliver strong operational growth... Full story

Yahoo Finance • 3 months ago

Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock?

American Century Investments, an investment management company, released its first-quarter 2026 investor letter for the “American Century Investments Small Cap Value Fund.”  A copy is available to download here. Equity markets encountered... Full story

Yahoo Finance • 3 months ago

3 Reasons ENOV is Risky and 1 Stock to Buy Instead

Over the last six months, Enovis’s shares have sunk to $22.66, producing a disappointing 16.1% loss - a stark contrast to the S&P 500’s 10% gain. This might have investors contemplating their next move. Is now the time to buy Enovis, or s... Full story

Yahoo Finance • 3 months ago

ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?

Key Points Fund increased Enovis stake by 384,124 shares; estimated trade size was $9.08 million based on quarterly average price. Quarter-end position value rose by $7.33 million, a figure reflecting both share purchases and price moveme... Full story

Yahoo Finance • 5 months ago

Enovis to Host First Quarter 2026 Results Conference Call on May 7th

Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quar... Full story

Yahoo Finance • 5 months ago

3 Healthcare Stocks with Open Questions

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and as a result, the industry has faired... Full story

Yahoo Finance • 6 months ago

Here are the major earnings before the open Thursday

Major earnings expected before the bell on Thursday include: * Viatris (VTRS [https://seekingalpha.com/symbol/VTRS]) * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * Vistance Networks (VISN [https://seekingalpha.com/symbol/VI... Full story

Yahoo Finance • 8 months ago

Canaccord Genuity Slashes PT on Enovis Corporation (ENOV) to $50 From $58

Enovis Corporation (NYSE:ENOV) is one of the best small cap stocks to buy with huge upside potential. Canaccord Genuity slashed the price target on Enovis Corporation (NYSE:ENOV) to $50 from $58 on December 17 and maintained a Buy rating o... Full story

Yahoo Finance • 9 months ago

An Enovis (ENOV) Insider Bets Big on the Stock With a Purchase of 2,468 Shares

Key Points John Kleckner reported an open market purchase of Enovis Corporation shares on Nov. 25, 2025. Kleckner is the principal accounting officer at Enovis Corporation.These 10 stocks could mint the next wave of millionaires › John K... Full story

Yahoo Finance • 10 months ago

ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds

Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the full year’s revenue to be around $2.26 b... Full story

Yahoo Finance • 10 months ago

Enovis raises 2025 adjusted EPS guidance to $3.10–$3.25 while sharpening portfolio focus

Earnings Call Insights: Enovis Corporation (ENOV) Q3 2025 MANAGEMENT VIEW * CEO Damien McDonald highlighted the company's "solid third quarter results reflect strong performance broadly across the portfolio as we increasingly focus on... Full story

Yahoo Finance • 10 months ago

Enovis Corporation beats top-line and bottom-line estimates; updates FY25 outlook

* Enovis Corporation press release [https://seekingalpha.com/pr/20296140-enovis-announces-third-quarter-2025-results] (ENOV [https://seekingalpha.com/symbol/ENOV]): Q3 Non-GAAP EPS of $0.75 beats by $0.10. * Revenue of $549M (+8.7% Y/Y... Full story